Alexander Le

Alexander Le

Texas Tech University Health Sciences Center - Lubbock / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5367553
person_outline Alexander Le's MOST POPULAR ARTICLES
1-) Management of immune-related adverse events associated with immune checkpoint inhibitor therapy: a minireview of current clinical guidelinesS Trinh, A Le, S Gowani, NM La-BeckAsia-Pacific journal of oncology nursing 6 (2), 154-160, 20191082019
2-) Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronateR Rajan, MK Sabnani, V Mavinkurve, H Shmeeda, H Mansouri, ...Journal of Controlled Release 271, 139-148, 2018662018
3-) Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in contextAD Le, SK Alzghari, GW Jean, NM La-BeckTherapeutics and Clinical Risk Management, 223-236, 2017232017
4-) Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung CancerNM La‐Beck, DT Nguyen, AD Le, SK Alzghari, ST TrinhPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (3 …, 2020192020
5-) Comparative landscape of actionable somatic alterations in advanced cholangiocarcinoma from circulating tumor and tissue-based DNA profiling.PM Kasi, AD Le, A BarrettJournal of Clinical Oncology 39 (3_suppl), 342-342, 202192021